Selected research
Industry Research
Tafenoquine Industry Research Report 2026
Market perspective
The global Tafenoquine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tafenoquine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tafenoquine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tafenoquine include Pharmacodia (Beijing) Co.,Ltd, Merck, GlaxoSmithKline Pharmaceuticals (GSK), WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., J & K Scientific LTD, BOC Sciences and Amadis Chemical Company Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tafenoquine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tafenoquine Market by Company
Pharmacodia (Beijing) Co.,Ltd
Merck
GlaxoSmithKline Pharmaceuticals (GSK)
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
J & K Scientific LTD
BOC Sciences
Amadis Chemical Company Limited
Tafenoquine Segment by Type
Powder
Pills
Tafenoquine Segment by Application
P. falciparum Treatment
Radical Cure of P.vivax
Prevention of Malaria Relapse
Tafenoquine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafenoquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tafenoquine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafenoquine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tafenoquine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tafenoquine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Pills
Applications
- P. falciparum Treatment
- Radical Cure of P.vivax
- Prevention of Malaria Relapse
Companies covered
- Pharmacodia (Beijing) Co.,Ltd
- Merck
- GlaxoSmithKline Pharmaceuticals (GSK)
- WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- J & K Scientific LTD
- BOC Sciences
- Amadis Chemical Company Limited
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tafenoquine Market Size (2021-2032)
- 2.2.2 Global Tafenoquine Sales (2021-2032)
- 2.2.3 Global Tafenoquine Market Average Price (2021-2032)
- 2.3 Tafenoquine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Powder
- 2.3.3 Pills
- 2.4 Tafenoquine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 P. falciparum Treatment
- 2.4.3 Radical Cure of P.vivax
- 2.4.4 Prevention of Malaria Relapse
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tafenoquine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tafenoquine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Tafenoquine Revenue of Manufacturers (2021-2026)
- 3.4 Global Tafenoquine Average Price by Manufacturers (2021-2026)
- 3.5 Global Tafenoquine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tafenoquine, Product Type & Application
- 3.8 Global Manufacturers of Tafenoquine, Established Date
- 3.9 Global Tafenoquine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pharmacodia (Beijing) Co.,Ltd
- 4.1.1 Pharmacodia (Beijing) Co.,Ltd Company Information
- 4.1.2 Pharmacodia (Beijing) Co.,Ltd Business Overview
- 4.1.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
- 4.1.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Tafenoquine Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 GlaxoSmithKline Pharmaceuticals (GSK)
- 4.3.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
- 4.3.2 GlaxoSmithKline Pharmaceuticals (GSK) Business Overview
- 4.3.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
- 4.3.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments
- 4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- 4.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
- 4.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview
- 4.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
- 4.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments
- 4.5 J & K Scientific LTD
- 4.5.1 J & K Scientific LTD Company Information
- 4.5.2 J & K Scientific LTD Business Overview
- 4.5.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 J & K Scientific LTD Tafenoquine Product Portfolio
- 4.5.5 J & K Scientific LTD Recent Developments
- 4.6 BOC Sciences
- 4.6.1 BOC Sciences Company Information
- 4.6.2 BOC Sciences Business Overview
- 4.6.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BOC Sciences Tafenoquine Product Portfolio
- 4.6.5 BOC Sciences Recent Developments
- 4.7 Amadis Chemical Company Limited
- 4.7.1 Amadis Chemical Company Limited Company Information
- 4.7.2 Amadis Chemical Company Limited Business Overview
- 4.7.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
- 4.7.5 Amadis Chemical Company Limited Recent Developments
5 Global Tafenoquine Market Scenario by Region
- 5.1 Global Tafenoquine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tafenoquine Sales by Region: 2021-2032
- 5.2.1 Global Tafenoquine Sales by Region: 2021-2026
- 5.2.2 Global Tafenoquine Sales by Region: 2027-2032
- 5.3 Global Tafenoquine Revenue by Region: 2021-2032
- 5.3.1 Global Tafenoquine Revenue by Region: 2021-2026
- 5.3.2 Global Tafenoquine Revenue by Region: 2027-2032
- 5.4 North America Tafenoquine Market Facts & Figures by Country
- 5.4.1 North America Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tafenoquine Sales by Country (2021-2032)
- 5.4.3 North America Tafenoquine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Tafenoquine Market Facts & Figures by Country
- 5.5.1 Europe Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tafenoquine Sales by Country (2021-2032)
- 5.5.3 Europe Tafenoquine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Tafenoquine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tafenoquine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tafenoquine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tafenoquine Market Facts & Figures by Country
- 5.7.1 South America Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tafenoquine Sales by Country (2021-2032)
- 5.7.3 South America Tafenoquine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Tafenoquine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tafenoquine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tafenoquine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Tafenoquine Sales by Type (2021-2032)
- 6.1.1 Global Tafenoquine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Tafenoquine Sales Market Share by Type (2021-2032)
- 6.2 Global Tafenoquine Revenue by Type (2021-2032)
- 6.2.1 Global Tafenoquine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tafenoquine Revenue Market Share by Type (2021-2032)
- 6.3 Global Tafenoquine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tafenoquine Sales by Application (2021-2032)
- 7.1.1 Global Tafenoquine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Tafenoquine Sales Market Share by Application (2021-2032)
- 7.2 Global Tafenoquine Revenue by Application (2021-2032)
- 7.2.1 Global Tafenoquine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tafenoquine Revenue Market Share by Application (2021-2032)
- 7.3 Global Tafenoquine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tafenoquine Value Chain Analysis
- 8.1.1 Tafenoquine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tafenoquine Production Mode & Process
- 8.2 Tafenoquine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tafenoquine Distributors
- 8.2.3 Tafenoquine Customers
9 Global Tafenoquine Analyzing Market Dynamics
- 9.1 Tafenoquine Industry Trends
- 9.2 Tafenoquine Industry Drivers
- 9.3 Tafenoquine Industry Opportunities and Challenges
- 9.4 Tafenoquine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst